• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  thymosin beta 4
Trade Name:  N/A
Date Designated:  12/31/2013
Orphan Designation:  Treatment of patients with neurotrophic keratopathy
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date:  N/A
Approved Labeled Indication:  
Exclusivity End Date:    N/A
ReGenTree, LLC
116 Village Blvd
Suite 200
Princeton, New Jersey 08540
USA

The sponsor address listed is the last reported by the sponsor to OOPD.
-
-